Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE2
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
- Status
- COMPLETED
- Phase
- PHASE1
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Status
- RECRUITING
- Phase
- PHASE2
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
- Status
- COMPLETED
- Phase
- NA
A Telehealth Advance Care Planning Intervention
- Status
- RECRUITING
- Phase
- NA
Allo HSCT Using RIC and PTCy for Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib in Patients With Myelofibrosis
- Status
- UNKNOWN
- Phase
- N/A
Clonal Architecture of ASXL1-mutated Myelofibrosis
- Status
- RECRUITING
- Phase
- NA
A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib
- Status
- COMPLETED
- Phase
- N/A
Managed Access Program for Momelotinib in Myelofibrosis
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE2
AlloHCT With PegINFa for Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis
- Status
- UNKNOWN
- Phase
- PHASE4